In focus
Carnyx Therapeutics Unveils Oral Sleep Candidate CNYX-005 Following Promising Preclinical Trials
Preclinical-stage biopharmaceutical firm Carnyx Therapeutics has introduced its lead oral sleep candidate, CNYX-005, demonstrating a significant increase in restorative NREM sleep in aged animal models.
Read the story